Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It’s pretty p**s poor. For something so important to the immediate needs of the business , there wasn’t enough checks and balances in the process.
On the bright side, it hasn’t done anything to negative to the share price.
Doesn’t the following statement suggest a fund raise from shareholders?
“ Subject to prevailing market conditions and upon taking independent advice, the Company intends to use its best efforts to raise net equity proceeds of £70m to facilitate these prepayments.”
I wouldn’t necessarily rule it out. I would however suggest that you do your own research as well and compare with other competitors. I sold my Wetherspoons a month ago as I read a rumour that indoor table service may remain for many months more. I W on’t be buying nto food and drink establishments until the Indian variant is sorted. Investing in that sector right now is a gamble. Anything that effects indoor food and drink capacity will impact heavily on income and profits.
If you go onto the HL website to login (you can’t do it on the app) - go to account settings and select “income instructions” you can chose to hold the dividend either in your dealing account, or direct to bank account
I’m not a holder, but have previously subscribed to other shares via PB.
I might have subscribed to this, but they give you so little time to do the research before it closed.
Sorry for the dumb question, but why is the SP only 57p when the offer is 67p. Isn’t it a money printing opportunity? Maybe I’m missing something
Scoobydoo - The connection is:
MXCT are developing CARMA, its platform for immuno-oncology to rapidly develop chimeric antigen receptor (CAR) therapies for a broad range of cancer indications including solid tumours where existing CAR-T approaches face challenges
Interesting short article in the Telegraph today:
Bitcoin for Banksy
Sotheby’s will accept payments in Bitcoin and Ethereum for the Banksy artwork Love is in the Air, a first for a physical art auction. The piece of street art is expected to fetch between $3m (£2.2m) and $5m in next week’s sale.
Lloy - the share that just keeps giving. I’ve been buying on dips and selling on spikes all through this past year, because my gut feeling is that with its U.K. focus and PPI largely out the way this share will slowly move to 60p over the next year.
Another bit from the Telegraph in their market update was positive as follows:
Biotech boosted by Covid test
The pandemic has transformed the fortunes of British biotech minnow Avacta, whose share price soared after clinical data showed its lateral flow test was highly accurate, Julia Bradshaw writes.
The test’s sensitivity and specificity, a metric used by the industry to determine accuracy, were 98pc and 99pc respectively, which is better than the leading lateral flow tests already on the market.
The news sent shares in Avacta up by more than 10pc to 270p, with analysts forecasting sales volumes could reach 20m this year, rising to 90m in 2022.
“This is hugely transformational for us and validates our platform,” said chief executive Dr Alastair Smith.
“It has been pivotal for the company and has significantly altered our valuation by a factor of more than 10 times, which allowed us to raise substantial capital last year, we suddenly got lots more interest from investors.”
I wouldn’t expect another RNS until the last week of April and that would be regarding rolling over banking covenants based on trading for 2-3 weeks. I don’t expect any unexpected bad news.
I don’t know if any of you have ever watched “Aussie Gold Hunters” on DMAX or Discovery tv, but these one, two, three man operations would put this company to shame. Ok, I accept that thee are significant differences to mining at depth and surface mining, but the glacial pace at which processing and assaying samples and old spoils is unbelievable.
Fairly dispassionate article in the Telegraph today about Avacta. The upshot of it all is hold.
https://www.telegraph.co.uk/investing/shares/questor-rapid-covid-tests-have-doubled-firms-share-price-can/